This trial is testing whether kids with a high threshold for peanut allergies can eat small amounts of peanuts to build up a tolerance, and if this changes their quality of life.
- Food Allergy
- Peanut Allergy
1 Primary · 6 Secondary · Reporting Duration: up to 96 weeks
2 Treatment Groups
1 of 2
1 of 2
73 Total Participants · 2 Treatment Groups
Primary Treatment: Treatment · No Placebo Group · Phase 2
Who is running the clinical trial?
Age 4 - 14 · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Will geriatric participants be included in this investigation?
"As indicated by the inclusionary criteria, this trial is open to those between 4 and 14 years old. Additionally, there are 88 studies for minors under 18 and 158 study opportunities available for people above 65." - Anonymous Online Contributor
Has the recruitment phase for this trial commenced?
"Affirmative. Clinicaltrials.gov's records demonstrate that this medical experiment, initially posted on August 5th 2019, is enrolling patients. 74 participants must be recruited from 1 of the available sites." - Anonymous Online Contributor
To whom is participation in this clinical trial being offered?
"This study is seeking 74 children aged 4 to 14 with a confirmed peanut allergy. To be eligible, the patient (or their guardian) must provide informed consent and have IgE levels of 0.35 kUA/L or higher after avoiding peanuts for at least three days before screening. Furthermore, patients should be able to consume between 143 mg and 5043 mg of peanut protein during oral food challenge testing on the day of screening. Informed consent from both parent(s)/guardian(s) and child are necessary in order to participate in this trial." - Anonymous Online Contributor
Does this medication have governmental sanctioning?
"Adequate prior evidence confirms that this therapeutic intervention is safe, and thus it has been awarded a score of 2 on the Power scale. However, since this is still a Phase 2 trial, data supporting efficacy remains absent." - Anonymous Online Contributor
What is the upper limit of participants in this experiment?
"That is correct. Clinicaltrials.gov shows that the trial, initially posted on August 5th 2019, is still seeking participants with 74 patients to be recruited from 1 location." - Anonymous Online Contributor